Advertisement
Australia markets close in 1 hour 45 minutes
  • ALL ORDS

    7,850.50
    -87.00 (-1.10%)
     
  • ASX 200

    7,589.10
    -93.90 (-1.22%)
     
  • AUD/USD

    0.6524
    +0.0000 (+0.01%)
     
  • OIL

    83.86
    +0.29 (+0.35%)
     
  • GOLD

    2,347.20
    +4.70 (+0.20%)
     
  • Bitcoin AUD

    98,616.25
    +275.35 (+0.28%)
     
  • CMC Crypto 200

    1,386.71
    +4.13 (+0.30%)
     
  • AUD/EUR

    0.6082
    +0.0009 (+0.14%)
     
  • AUD/NZD

    1.0952
    -0.0006 (-0.05%)
     
  • NZX 50

    11,819.74
    -126.69 (-1.06%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    17,917.28
    -171.42 (-0.95%)
     
  • Hang Seng

    17,626.75
    +342.21 (+1.98%)
     
  • NIKKEI 225

    37,909.98
    +281.50 (+0.75%)
     

Monsanto rejects Bayer $62 bn bid as 'financially inadequate'

US agricultural giant Monsanto says a raised takeover bid from Germany's Bayer is insufficient

US agribusiness giant Monsanto Co. rejected Tuesday the $62 billion takeover bid by Germany's Bayer AG as too low, but said it was willing to entertain further talks on a merger.

Monsanto chairman and chief executive Hugh Grant said in a statement that the offer "significantly undervalues our company" and does not give enough assurance on how Bayer would finance the deal or overcome possible regulatory challenges.

Monsanto's board "unanimously views the Bayer AG proposal as incomplete and financially inadequate, but is open to continued and constructive conversations to assess whether a transaction in the best interest of Monsanto shareowners can be achieved," the statement said.

Bayer made what amounts to the largest-ever takeover offer by a German company on Monday for the world leader in seeds, farm pesticides and genetically modified crops.

ADVERTISEMENT

The $122 a share cash offer sent Monsanto shares surging but only to $106 amid expectations of Monsanto's rejection and questions over whether Bayer would increase the bid. Bayer shares had tumbled on the news.

Monsanto's shares were up 1.7 percent to $107.77 in early afternoon trade Tuesday.

Bayer shares traded in Frankfurt had fallen last week on expectations of the proposal, and dropped another 5.7 percent to 84.42 euros ($94.09) on Monday.

With unconfirmed reports of Monsanto's coming rejection already in the markets, Bayer shares rebounded 3.2 percent Tuesday to 87.15 euros.

The German giant, a global power in pharmaceuticals, consumer health products, and crop science, called the proposed merger "an extraordinary opportunity to create a global leader in the agricultural industry. Monsanto is a perfect match to our agricultural business."

"The agriculture industry is at the heart of one of the greatest challenges of our time: how to feed an additional three billion people in the world by 2050," said Bayer chief executive Werner Baumann.

According to The Wall Street Journal, the two companies would together account for around 28 percent of global sales of pesticides and herbicides.